SCHEMBL1990972

SCHEMBL1990972

CN1CCC(n2nc(C3=C(c4c[nH]c5sccc45)C(=O)NC3=O)c3ccccc32)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCB P05771 18/20 0.51
PRKCA P17252 18/20 0.51
PRKCD Q05655 18/20 0.51
PRKCE Q02156 17/20 0.51
PRKCH P24723 17/20 0.51
CAMK2D Q13557 4/20 0.51
PRKCG P05129 4/20 0.51
PRKCZ Q05513 3/20 0.51
CAMK2B Q13554 3/20 0.51
CAMK2G Q13555 3/20 0.51
CAMK2A Q9UQM7 3/20 0.51
SRC P12931 1/20 0.51
PRKCQ Q04759 15/20 0.44
GSK3B P49841 3/20 0.44
PDPK1 O15530 1/20 0.44
DYRK3 O43781 1/20 0.44
PRKD3 O94806 1/20 0.44
MAP4K4 O95819 1/20 0.44
ABL1 P00519 1/20 0.44
EGFR P00533 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1991764 0.90 CAMK2D (0.44) PRKCBPRKCAPRKCDPRKCEPRKCH
SCHEMBL1994823 0.89 PRKCA (0.43) PRKCBPRKCAPRKCDPRKCEPRKCH
SCHEMBL1991096 0.89 PRKCA (0.39) PRKCBPRKCAPRKCDPRKCEPRKCH
SCHEMBL1999066 0.89 PRKCG (0.43) PRKCBPRKCAPRKCDPRKCEPRKCH
SCHEMBL1997672 0.89 PRKACA (0.43) PRKCBPRKCAPRKCDPRKCEPRKCH
SCHEMBL1997712 0.89 PRKCA (0.42) PRKCBPRKCAPRKCDPRKCEPRKCH
SCHEMBL1992211 0.88 CAMK2D (0.40) PRKCBPRKCAPRKCDPRKCEPRKCH
SCHEMBL12563790 0.88 CAMK2D (0.40) PRKCBPRKCAPRKCDPRKCEPRKCH
SCHEMBL1989963 0.87 PRKCB (0.38) PRKCBPRKCAPRKCDPRKCEPRKCH
SCHEMBL1996716 0.87 CAMK2D (0.39) PRKCBPRKCAPRKCDPRKCEPRKCH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011079105-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-30 WO disclosed
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-23 US disclosed
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-23 US disclosed
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS TPMT, TSLP, THPO PRKCB 3335/4885PRKCA 3438/4885PRKCD 2857/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.